Haisco Pharmaceutical's (SHE:002653) attributable profit ballooned 427%, or about 5.3 times, to 851.2 million yuan in the first half from 161.5 million yuan, after adjustments, in the year-ago period, according to a Thursday filing with the Shanghai/Shenzhen Stock Exchange.
Earnings per share at the drug company expanded to 0.7601 yuan from 0.1442 yuan in the prior-year period.
Operating revenue grew 55% year over year to 3.10 billion yuan from 2.00 billion yuan.
Directors declared a dividend of 5.26 yuan per 10 shares, or 0.526 yuan per share.